PhaseBio: PhaseBio Pharmaceuticals, Inc. Announces Resignation of John P. Sharp as Chief Financial Officer, Effective November 30, 2022

On November 21, 2022, John P. Sharp, Chief Financial Officer of PhaseBio Pharmaceuticals, Inc., informed the company that he was resigning from his position, effective November 30, 2022, to pursue another employment opportunity.